VOYA Investment Management’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-28,358
Closed -$7.23K 3073
2023
Q1
$7.23K Hold
28,358
﹤0.01% 2882
2022
Q4
$33.5K Hold
28,358
﹤0.01% 2887
2022
Q3
$57.9K Buy
+28,358
New +$48.1K ﹤0.01% 2878

VOYA Investment Management's PEAR Position: Q2 2023 in Review

VOYA Investment Management sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q2 2023, closing a stake of 28,358 shares — an estimated $7.23K sold.

VOYA Investment Management first reported a position in PEAR in Q3 2022 and held it in 3 quarters. The position peaked at $57.9K in Q3 2022. 1 fund tracked by Wall St. Rank holds PEAR as of Q2 2023.

  • VOYA Investment Management reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • VOYA Investment Management sold 28,358 Pear Therapeutics, Inc. Class A Common Stock shares in Q2 2023, an estimated $7.23K.
  • VOYA Investment Management first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q3 2022 and held it in 3 quarters.
  • VOYA Investment Management's Pear Therapeutics, Inc. Class A Common Stock position peaked at $57.9K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q2 2023.

Based on VOYA Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.